Hypertension during high-dose ketoconazole treatment: a probable mineralocorticosteroid effect
- PMID: 2887934
- DOI: 10.1016/s0140-6736(87)93039-x
Hypertension during high-dose ketoconazole treatment: a probable mineralocorticosteroid effect
Similar articles
-
The endocrine effect of ketoconazole high doses (KHD).Prog Clin Biol Res. 1987;243A:291-7. Prog Clin Biol Res. 1987. PMID: 3659001 No abstract available.
-
Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castration.BJU Int. 2011 Jul;108(2):223-7. doi: 10.1111/j.1464-410X.2010.09825.x. Epub 2010 Nov 15. BJU Int. 2011. PMID: 21078047 Clinical Trial.
-
Ketoconazole high dose (H.D.) in the management of hormonally pretreated patients with progressive metastatic prostate cancer.Prog Clin Biol Res. 1987;243A:301-13. Prog Clin Biol Res. 1987. PMID: 3659003
-
Ketoconazole as a secondary hormonal intervention in advanced prostate cancer.Clin J Oncol Nurs. 2006 Jun;10(3):361-6. doi: 10.1188/06.CJON.361-366. Clin J Oncol Nurs. 2006. PMID: 16789581 Review. No abstract available.
-
Ketoconazole in advanced prostate cancer.Ann Pharmacother. 1992 Dec;26(12):1527-9. Ann Pharmacother. 1992. PMID: 1482810 Review. No abstract available.
Cited by
-
Characterization of the interferences of systemic azole antifungal drugs with adrenal steroid biosynthesis using H295R cells and enzyme activity assays.Curr Res Toxicol. 2023 Aug 14;5:100119. doi: 10.1016/j.crtox.2023.100119. eCollection 2023. Curr Res Toxicol. 2023. PMID: 37637492 Free PMC article.
-
Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma.J Clin Oncol. 2009 Sep 20;27(27):4619-29. doi: 10.1200/JCO.2008.17.2775. Epub 2009 Aug 10. J Clin Oncol. 2009. PMID: 19667279 Free PMC article. Review.
-
The use of other drugs to allow a lower dosage of cyclosporin to be used. Therapeutic and pharmacoeconomic considerations.Clin Pharmacokinet. 1997 May;32(5):357-67. doi: 10.2165/00003088-199732050-00002. Clin Pharmacokinet. 1997. PMID: 9160170 Review.
-
The treatment of advanced prostate cancer with ketoconazole: safety issues.Drug Saf. 1999 May;20(5):451-8. doi: 10.2165/00002018-199920050-00005. Drug Saf. 1999. PMID: 10348095 Review.
-
Assessment of the potential risk of oteseconazole and two other tetrazole antifungals to inhibit adrenal steroidogenesis and peripheral metabolism of corticosteroids.Front Pharmacol. 2024 Aug 8;15:1394846. doi: 10.3389/fphar.2024.1394846. eCollection 2024. Front Pharmacol. 2024. PMID: 39175536 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical